Urology, Uro-oncology and Sexology Update

6 2 Figure 3. Overall Survival NE, not estimable. 2 The treatment effect for OS in the pre-specied subgroup analysis is presented in Figure 4 below. 2 Figure 4. Overall Survival Subgroup Analysis CI, condence interval; ECOG, Eastern Cooperative Oncology Group performance status; HR, hazard ratio; NE, not estimable; PSA, prostate-specic antigen. UROLOGY, URO-ONCOLOGY AND SEXOLOGY UPDATE

RkJQdWJsaXNoZXIy NTIyOTQ=